Journal of Hepatology
Volume 39 , Pages 36-42 , 2003

Immunopathogenesis of hepatitis B

References 

  1. Guidotti GG, Chisari FV. Non-cytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol. 2001;19:65–91
  2. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996;4:25–36
  3. Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MB, et al.  Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA. 1996;93:4589–4594
  4. Heise T, Guidotti LG, Cavanaugh VJ, Chisari FV. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol. 1999;73:474–481
  5. Franco A, Guidotti LG, Hobbs MV, Pasquetto V, Chisari FV. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J Immunol. 1997;159:2001–2008
  6. Marrack P, Kappler J. Subversion of the immune system by pathogens. Cell. 1994;76:323–332
  7. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med. 2000;192:921–930
  8. Kakimi K, Lane TE, Chisari FV, Guidotti LG. Inhibition of hepatitis B virus replication by activation of NKT cells does not require inflammatory cell recruitment to the liver. J Immunol. 2001;167:6701–6705
  9. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. Activation of a non-classical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity. 2002;16:583–594
  10. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense. Annu Rev Immunol. 1999;17:189–220
  11. Bendelac A, Bonneville M, Kearney JF. Autoreactivity by design: innate B and T lymphocytes. Nat Rev. 2001;1:177–186
  12. von Adrian UH, Mackay CR. T cell function and migration. Two sides of the same coin. N Engl J Med. 2000;343:1020–1034
  13. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors and memory cells. Science. 2000;290:92–97
  14. Doherty PC, Allan W, Eichelberger M, Carding SR. Roles of αβ and γδ T cell subsets in viral immunity. Annu Rev Immunol. 1992;10:123–151
  15. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331–360
  16. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science. 1999;284:825–829
  17. Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, et al.  Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology. 2000;32:1117–1124
  18. Jilbert AR, Wu TT, England JM, Hall PM, Carp NZ, O'Connell AP, et al.  Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol. 1992;66:1377–1388
  19. Maini MK, Boni C, Ogg GS, King AS, Reignat S, Lee CK, et al.  Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection. Gastroenterology. 1999;117:1–13
  20. Ferrari C, Penna A, Bertoletti A, Valli A, Degli Antoni A, Giuberti T, et al.  Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol. 1990;145:3442–3449
  21. Jung MC, Spengler U, Schraut W, Hoffmann R, Zachoval R, Eisenburg J, et al.  Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis. Br J Hepatol. 1991;13:310–317
  22. Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, et al.  Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest. 1991;88:214–222
  23. Penna A, Del Prete G, Cavalli A, Bertoletti A, D'Elios MM, Sorrentino R, et al.  Predominant T helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 1997;25:1022–1027
  24. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol. 1995;13:29–60
  25. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, et al.  Long-lasting memory T cell responses following self-limited acute hepatitis. J Clin Invest. 1996;98:1185–1194
  26. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996;2:1104–1108
  27. Oldstone MD. Molecular anatomy of viral persistence. J Virol. 1991;65:6381–6386
  28. Stephan W, Prince AM, Brotman B. Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen. J Virol. 1984;51:420–424
  29. Milich DR, McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science. 1986;234:1398–1401
  30. Bottcher B, Wynne SA, Crowther RA. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature. 1997;386:88–91
  31. Conway JF, Cheng N, Zlotnich A, Wingfield PT, Stahl SJ, Steven A. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature. 1997;386:91–94
  32. Milich DR, Chen M, Schodel F, Peterson DL, Jones JE, Hughes JL. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci USA. 1997;94:14648–14653
  33. Lazdina U, Cao T, Steinbergs J, Alheim M, Pumbens P, Peterson DL, et al.  Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor of naı̈ve B cells. J Virol. 2001;75:6367–6374
  34. Penna A, Chisari FV, Bertoletti A, Giuberti T, Fowler P, Missale G. Cytotoxic T lymphocytes recognize an HLA A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med. 1991;174:1565–1570
  35. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, et al.  HLA-A31 and HLA-Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med. 1993;177(3):751–762
  36. Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, et al.  HLA-A2-restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol. 1993;150:4659–4671
  37. Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, et al.  Department of Molecular and Experimental Medicine. Scripps Research Instit. The cytotoxic T lymphocyte response to multiple hepatitis B polymerase epitopes during and after acute viral infection. J Exp Med. 1995;181:1047–1058
  38. Reignat S, Webster GJM, Brown D, Ogg GS, King A, Seneviratne SL, et al.  Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med. 2002;195:1089–1101
  39. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, et al.  The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med. 2000;191:1269–1280
  40. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, et al.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest. 1992;89:87–96
  41. Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest. 1997;99:3025–3033
  42. Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR. The serology of chronic hepatitis B infection revisited. J Clin Invest. 1993;91:2586–2595
  43. Sallberg MC, Thung SN, Hughes J, Jones J, Milich DR. Non-deletional T-cell receptor transgenic mice: model for the CD4+ T-cell repertoire in chronic hepatitis B virus infection. J Virol. 2000;74:7587–7599
  44. Bertoletti A, Ferrari C, Penna A, Fiaccadori F, Margolskee R, Schlicht HJ, et al.  HLA class I restricted cytotoxic T cells in acute viral hepatitis type B. Proc Natl Acad Sci USA. 1991;88:10445
  45. Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, et al.  Activation of a heterogeneous hepatitis B core and e antigen-specific CD4+ T cell-population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol. 1995;69:3358–3368
  46. Diepolder HM, Ries G, Jung MC, Schlicht HJ, Gerlach JT, Gruner N, et al.  Differential antigen-processing pathways of the hepatitis B virus e and core proteins. Gastroenterology. 1999;116:650–657
  47. Brunetto MR. Pre-core/core gene mutants of hepatitis B virus: pathogenetic implications. In:  Rizzetto M,  Purcel R,  Gerin J,  Verme G editor. Viral hepatitis and liver diseases. Turin: Edizioni Minerva Medica; 1997;p. 127–137
  48. Ferrari C, Mondelli MU, Penna A, Fiaccadori F, Chisari FV. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol. 1987;139:539–544
  49. Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, et al.  Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol. 1987;139:2050–2058
  50. Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F. Recognition of hepatitis B envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol. 1989;143:2650–2655
  51. Barnaba V, Franco A, Paroli M, Benvenuto R, De Petrillo G, Burgio VL, et al.  Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol. 1994;152:3074–3087
  52. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, et al.  Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology. 1997;112:193–199
  53. Maruyama T, Iino S, Koike K, Yasuda K, Milich DR. Serology of acute exacerbation in chronic hepatitis B. Gastroenterology. 1993;105:1141–1151
  54. Ferrari C, Chisari FV. Immune mechanisms of viral clearance and disease pathogenesis during viral hepatitis. In:  Arias IM,  Boyer JL,  Chisari FV,  Fausto N,  Schachter D,  Shafritz DA editor. The liver. Biology and pathobiology. Philadelphia: Lippincott Williams & Wilkins; 2001;p. 763–782
  55. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?. Proc Natl Acad Sci USA. 1990;87:6599–6604
  56. Milich DR, Schodel F, Peterson DL, Jones JE, Hughes JL. Chracterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol. 1995;25:1663–1672
  57. Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, et al.  Lamivudine treatment can restore T cell responsiveness in chronic hepatitis. J Clin Invest. 1998;102:968–975
  58. Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavalo C, et al.  Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology. 2001;33:963–971
  59. Milich DR, Schodel F, Hughes JL, Jones JE, Peterson D. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol. 1997;71:2192–2201
  60. Milich DR, Chen MK, Hughes JL, Jones JE. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol. 1998;160:2013–2021
  61. Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV. CTL access to tissue antigen is restricted in vivo. J Immunol. 1994 Jul 15;153(2):482–488
  62. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al.  Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med. 1995;182:1223–1230
  63. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189–1192
  64. Limmer A, Ohl J, Kurts C, Ljunggren H-G, Reiss Y, Groettrup M, et al.  Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T cell tolerance. Nat Med. 2000;6:1348–1354
  65. Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature. 1990;315:258–260
  66. Schrimbeck R, Melber K, Kuhrober A, Janowicz ZA, Reimann J. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. J Immunol. 1994;152:1110–1119
  67. Schrimbeck R, Melber K, Mertens T, Reimann J. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J Virol. 1994;68:1418–1425
  68. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med. 1994;180:933–943
  69. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, et al.  Natural variants of cytotoxic epitopes are T cell receptor antagonists for anti-viral cytotoxic T cells. Nature. 1994;369:407–410

PII: S0168-8278(03)00137-5

doi: 10.1016/S0168-8278(03)00137-5

Journal of Hepatology
Volume 39 , Pages 36-42 , 2003

Article Tools